Oppenheimer Initiates Coverage of Complete Genomics with 'Outperform' Rating

An Oppenheimer analyst noted the quality of Complete Genomics' data, a continued demand for sequencing service providers, and the progression of sequencing into clinical applications.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.